125 related articles for article (PubMed ID: 10077456)
1. Activin/follistatin and atherosclerosis--a review.
Kozaki K; Ouchi Y
J Atheroscler Thromb; 1998; 5(1):36-40. PubMed ID: 10077456
[TBL] [Abstract][Full Text] [Related]
2. Role of activin-A and follistatin in foam cell formation of THP-1 macrophages.
Kozaki K; Akishita M; Eto M; Yoshizumi M; Toba K; Inoue S; Ishikawa M; Hashimoto M; Kodama T; Yamada N; Orimo H; Ouchi Y
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2389-94. PubMed ID: 9409206
[TBL] [Abstract][Full Text] [Related]
3. Expression of follistatin, an activin-binding protein, in vascular smooth muscle cells and arteriosclerotic lesions.
Inoue S; Orimo A; Hosoi T; Matsuse T; Hashimoto M; Yamada R; Ouchi Y; Orimo H; Muramatsu M
Arterioscler Thromb; 1993 Dec; 13(12):1859-64. PubMed ID: 8241108
[TBL] [Abstract][Full Text] [Related]
4. Activin and follistatin as local regulators in the human ovary.
Peng C; Ohno T; Khorasheh S; Leung PC
Biol Signals; 1996; 5(2):81-9. PubMed ID: 8836491
[TBL] [Abstract][Full Text] [Related]
5. Human activin-A is expressed in the atherosclerotic lesion and promotes the contractile phenotype of smooth muscle cells.
Engelse MA; Neele JM; van Achterberg TA; van Aken BE; van Schaik RH; Pannekoek H; de Vries CJ
Circ Res; 1999 Nov; 85(10):931-9. PubMed ID: 10559140
[TBL] [Abstract][Full Text] [Related]
6. The activin-binding protein follistatin is expressed in developing murine molar and induces odontoblast-like cell differentiation in vitro.
Heikinheimo K; Bègue-Kirn C; Ritvos O; Tuuri T; Ruch JV
J Dent Res; 1997 Oct; 76(10):1625-36. PubMed ID: 9326894
[TBL] [Abstract][Full Text] [Related]
7. Follistatin as an activin-binding protein expressed in arteriosclerotic lesions.
Inoue S; Orimo A; Hosoi T; Matsuse T; Kozaki K; Ouchi Y; Muramatsu M; Orimo H
Ann N Y Acad Sci; 1995 Jan; 748():530-3. PubMed ID: 7695198
[No Abstract] [Full Text] [Related]
8. Isolation and characterization of Xenopus follistatin and activins.
Fukui A; Nakamura T; Sugino K; Takio K; Uchiyama H; Asashima M; Sugino H
Dev Biol; 1993 Sep; 159(1):131-9. PubMed ID: 8365557
[TBL] [Abstract][Full Text] [Related]
9. Demonstration of activin-A in arteriosclerotic lesions.
Inoue S; Orimo A; Hosoi T; Ikegami A; Kozaki K; Ouchi Y; Nomura S; Muramatsu M; Orimo H
Biochem Biophys Res Commun; 1994 Nov; 205(1):441-8. PubMed ID: 7999062
[TBL] [Abstract][Full Text] [Related]
10. Release of activin and follistatin during cardiovascular procedures is largely due to heparin administration.
Phillips DJ; Jones KL; McGaw DJ; Groome NP; Smolich JJ; Pärsson H; de Kretser DM
J Clin Endocrinol Metab; 2000 Jul; 85(7):2411-5. PubMed ID: 10902786
[TBL] [Abstract][Full Text] [Related]
11. The heparin binding site of follistatin is involved in its interaction with activin.
Sumitomo S; Inouye S; Liu XJ; Ling N; Shimasaki S
Biochem Biophys Res Commun; 1995 Mar; 208(1):1-9. PubMed ID: 7887917
[TBL] [Abstract][Full Text] [Related]
12. A novel role of follistatin, an activin-binding protein, in the inhibition of activin action in rat pituitary cells. Endocytotic degradation of activin and its acceleration by follistatin associated with cell-surface heparan sulfate.
Hashimoto O; Nakamura T; Shoji H; Shimasaki S; Hayashi Y; Sugino H
J Biol Chem; 1997 May; 272(21):13835-42. PubMed ID: 9153241
[TBL] [Abstract][Full Text] [Related]
13. Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation.
Di Simone N; Crowley WF; Wang QF; Sluss PM; Schneyer AL
Endocrinology; 1996 Feb; 137(2):486-94. PubMed ID: 8593793
[TBL] [Abstract][Full Text] [Related]
14. Derangements in the activin-follistatin system in hepatoma cells.
Mashima H; Kanzaki M; Nobusawa R; Zhang YQ; Suzuki M; Mine T; Kojima I
Gastroenterology; 1995 Mar; 108(3):834-40. PubMed ID: 7875486
[TBL] [Abstract][Full Text] [Related]
15. The activin A-follistatin system: potent regulator of human extracellular matrix mineralization.
Eijken M; Swagemakers S; Koedam M; Steenbergen C; Derkx P; Uitterlinden AG; van der Spek PJ; Visser JA; de Jong FH; Pols HA; van Leeuwen JP
FASEB J; 2007 Sep; 21(11):2949-60. PubMed ID: 17449718
[TBL] [Abstract][Full Text] [Related]
16. Uterine-embryonic interaction in pig: activin, follistatin, and activin receptor II in uterus and embryo during early gestation.
van de Pavert SA; Boerjan ML; Stroband HW; Taverne MA; van den Hurk R
Mol Reprod Dev; 2001 Aug; 59(4):390-9. PubMed ID: 11468775
[TBL] [Abstract][Full Text] [Related]
17. Expression of FLRG, a novel activin A ligand, is regulated by TGF-beta and during hematopoiesis [corrected].
Maguer-Satta V; Bartholin L; Jeanpierre S; Gadoux M; Bertrand S; Martel S; Magaud JP; Rimokh R
Exp Hematol; 2001 Mar; 29(3):301-8. PubMed ID: 11274757
[TBL] [Abstract][Full Text] [Related]
18. Follistatin binds to both activin and inhibin through the common subunit.
Shimonaka M; Inouye S; Shimasaki S; Ling N
Endocrinology; 1991 Jun; 128(6):3313-5. PubMed ID: 2036994
[TBL] [Abstract][Full Text] [Related]
19. Unique recognition of activin and inhibin by polyclonal antibodies to inhibin subunits.
Funaba M; Murata T; Fujimura H; Murata E; Abe M; Takahashi M; Torii K
J Biochem; 1996 May; 119(5):953-60. PubMed ID: 8797097
[TBL] [Abstract][Full Text] [Related]
20. Expression of inhibin/activin subunits and follistatin messenger ribonucleic acids and proteins in ovarian follicles and the corpus luteum during the human menstrual cycle.
Roberts VJ; Barth S; el-Roeiy A; Yen SS
J Clin Endocrinol Metab; 1993 Nov; 77(5):1402-10. PubMed ID: 8077341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
